SCHEMBL24535698

SCHEMBL24535698

CC1(O)CCCN(c2nc(OCC34CCCN3CCC4)nc3c(F)c(Cl)ncc23)C1

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 20/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29679998 1.00 KRAS (0.51) KRAS
SCHEMBL24535692 1.00 KRAS (0.51) KRAS
SCHEMBL30706592 0.90 KRAS (0.44) KRAS
SCHEMBL24536089 0.90 KRAS (0.56) KRAS
SCHEMBL30707184 0.90 KRAS (0.44) KRAS
SCHEMBL24535718 0.90 KRAS (0.56) KRAS
SCHEMBL24535697 0.90 KRAS (0.56) KRAS
SCHEMBL29680243 0.90 KRAS (0.56) KRAS
SCHEMBL30922600 0.90 KRAS (0.49) KRAS
SCHEMBL24536098 0.90 KRAS (0.49) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 — — WO disclosed
Send feedback